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Background: Human mesenchymal stromal cells from the bone marrow (BMSCs) are widely used as experimental
regenerative treatment of ischemic heart disease, and the first clinical trials using adipose-derived stromal cells (ASCs)
are currently being conducted. Regenerative mechanisms of BMSCs and ASCs are manifold and in vitro pretreatment
of the cells with growth factors has been applied to potentially enhance these properties. When characterizing the
transcriptional activity of these cellular mechanisms in vitro it is important to consider the effect of the growth factor
treatment on reference genes (RGs) for the normalization of qPCR data.
Results: BMSCs and ASCs were stimulated with vascular endothelial growth factor A-165 (VEGF) for one week, and
compared with un-stimulated cells from the same donor. The stability of nine RGs through VEGF treatment as
well as the donor variation was assessed using the GenEx software with the subprograms geNorm and Normfinder.
The procedure of stepwise elimination was validated by poor performance of eliminated RGs in a normalization
experiment using vWF as target gene. Normfinder found the TATA box binding protein (TBP) to be the most stable
single RG for both BMSCs and ASCs. The optimal number of RGs for ASCs was two, and the lowest variance for vWF
normalization was found using TBP and YWHAZ. For BMSCs, the optimal number of RGs was four, while the two-RG
combination producing the most similar results was TBP and YWHAZ.
Conclusions: A common reference gene, TBP, was found to be the most stable standalone gene, while TBP and
YWHAZ were found to be the best two-RG combination for qPCR analyses for both BMSCs and ASCs through the
VEGF stimulation. The presented stepwise elimination procedure was validated, while we found the final
normalization experiment to be essential.
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Vascular endothelial growth factor, VEGFBackground
Human bone marrow derived stromal cells (BMSCs) and
adipose-derived stromal cells (ASCs) have made a sig-
nificant impact on the field of regenerative medicine.
Within the field of cardiac regeneration, BMSCs have
been used frequently in clinical trials while the first clin-
ical trials with ASCs stimulated with vascular endothelial
growth factor (VEGF) is currently being conducted
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unless otherwise stated.investigated cell type, however adipose tissue has re-
ceived increasing interest as a source of stem cells due to
easier harvest, a larger yield of stem cells and the fact that
ASCs possess higher proliferative capacity compared to
BMSCs [3]. The rationale behind the potential benefit of
using the two cell types has primarily been suggested on
the basis of their immunoregulatory properties, paracrine
profiles, and capability to differentiate into various cell
types [4-9]. When investigating these properties and how
to enhance them in vitro, the first change within the cells
is found at the transcriptional level. This change is de-
tectable by quantitative real time polymerase chain reac-
tion (qPCR) analyses, which is the preferred method for
detecting changes in gene expression [10]. However, theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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mental setup that may affect results. These errors could
occur at different stages throughout the experiment and
encompass variations in the amount of starting material,
nuclear extraction, RNA integrity, cDNA loading, reverse
transcription, and qPCR efficiency [11]. Thus, in order to
compare qPCR results from different runs, or samples
obtained from different tissues at various time points, a
normalization step is necessary [12].
The most widely used method for normalizing qPCR
data is comparison to values from reference genes (RGs)
analyzed simultaneously on the same material [13]. The
abundance of the normalization candidate gene must be
closely related to the total amount of mRNA in the sam-
ple, in order to be able to correct for experimental errors
[14]. In addition, it must exhibit stable expression during
experimental conditions to be useful for normalization.
Often an invariant endogenous gene is used as a RG
with a constant expression level across all samples and
experimental treatments. If the RGs are not stable
through the treatment it could obscure actual changes
and produce artifacts that contribute to misleading
results and incorrect conclusions, thereby leading to un-
reliable publications [13]. The attention regarding selec-
tion of suitable RGs has increased in the past decade,
from the geometric mean normalization proposed by
Vandesompele et al., to experiment-specific RG investi-
gations, and ultimately the “Minimum Information for
Publication of Quantitative Real-Time PCR Experiments”
(MIQE) guidelines [14,15]. The guidelines function as a
universal checklist that investigators can follow, to produce
the most reliable data when using qPCR [10].
In the field of cardiac regeneration, it has been pro-
posed that endothelium-committed cells greatly enhance
cell therapy outcome [16]. Ongoing clinical trials per-
formed by our group serve to differentiate ASCs and
BMSCs toward endothelial lineage for enhancement
of angiogenic potential by stimulation with vascular
endothelial growth factor (VEGF) [2,17,18]. This pro-
angiogenic growth factor is known to promote endothe-
lial cell proliferation, migration, and vessel permeability,
and to differentiate BMSCs toward endothelial lineage
[19,20]. The impact of VEGF treatment on ASCs and
BMSCs is tested in vitro by the use of qPCR, where it is
very important for both cell types to have established
RGs that are stable through the VEGF treatment. A suit-
able RG in ASCs is not necessarily stable in BMSCs,
therefore, it is important to validate whether the chosen
RGs can be used in both cell sources under specific
experimental conditions. No studies comparing choice of
RGs between ASCs and BMSCs have been conducted
previously to the authors’ knowledge, which makes this
study particularly interesting with regard to the ongoing
debate of differences and similarities between these twocell types. Through this study we provide a simple step-
wise selection procedure for choosing the RGs with focus
on the impact on the final outcome. For the purpose we
use specially designed software GenEx, more specifically
the algorithms Normfinder and geNorm [14,21].
Results
To be able to apply the qPCR on VEGF pre-conditioned
human mesenchymal stromal cells from the bone mar-
row and adipose tissue, a panel of RGs (Table 1) from
relevant literature was chosen to find the correct RG for
normalization. After confirming RNA purity, RNA integ-
rity, primer efficiency, and products (Figure 1), a stepwise
elimination of candidate RGs was performed in order to
select the best-suited RG(s) from a list of acceptable ones.
RNA and primer quality
RNA purity was validated by excluding protein contamin-
ation with absorbance ratios of 1.8-2.2 at 260 nm/280 nm.
RNA integrity was confirmed by RIN values of 10 for all
donors (Additional file 1: Table S1). Primers (Table 1) for
the qPCR were validated by dissociation curves (Additional
file 1: Figure S1) and by efficiencies (E ¼ 10 −1slope−1
 
∙100Þ
of 100% ±10% with a correlation coefficient R2 between
0.985 and 1.0 (Additional file 1: Table S2).
RG candidate selection
Step 1: RG candidate expression levels
The RG candidate Cq values were generally between 15
and 25 cycles, with no great difference between the
VEGF treatment group and the control group for either
ASCs or BMSCs (Figure 2). The selected RGs should
preferably be expressed in amounts close to those of the
target genes. The raw data for the outliers provided us
with Cq values that were substantially lower than that of
the gene of interest, as depicted in Figure 2 presenting
median Cq values. Reference genes with a substantially
greater difference in abundance compared to the gene of
interest are not suitable. It would be incorrect to per-
form an analysis on putative reference genes that are
unsuitable to be considered. Here our cutoff Cq value
difference is 10 cycles. In order not to reduce the initial
panel of reference genes completely, we didn’t exclude
more than the three genes mentioned at this stage.
We have investigated the impact of VEGF treatment
in terms of initiation of endothelial differentiation in
ASCs and BMSCs, after which endothelial target genes
such as vWF are expressed in relatively low amounts,
and therefore detected around 30 cycles. Since EF1-α,
ACTB, and 18S rRNA were the most abundant RGs in
both ASCs and BMSCs, with Cq values far from our tar-
get, they were removed from the panel (Figure 2). This
Table 1 Reference genes for qPCR
Gene Gene NCBI reference
sequence
Forward sequence Cellular function
18SrRNA 18S ribosomal RNA NR_003286.2 F = 5’-GTAACCCGTTGAACCCCATT-3’ Small subunit of cytoplasmic
ribosomes
R = 5’-CCATCCAATCGGTAGTAGCG-3’
ACTB beta-actin NM_001101.3 F = 5’-CCTTTTTGTCCCCCAACTTGA-3’ Cytoskeleton structural protein;
motility, cytokinesis
R = 5’-TGGCTGCCTCCACCCA-3’




NM_002046.4 F = 5’-CAACGGATTTGGTCGTATTGG-3’ Oxido-reductase in glycolysis and
gluconeogenesis, transcription
activation, apoptosisR = 5’-GCAACAATATCCACTTTACCAGAGTTAA-3’
GUSB beta-glucuronidase NM_000181.3 F = 5’-CTCATTTGGAATTTTGCCGATT-3’ Catalyzing hydrolysis of
B-D-glucuronic acid
R = 5’-CCGAGTGAAGATCCCCTTTTTA-3’
PPIA peptidyl prolyl isomerase A NM_021130.3 F = 5’-TCCTGGCATCTTGTCCATG-3’ Protein folding
R = 5’-CCATCCAACCACTCAGTCTTG-3’
RPL13 ribosomal protein L13a NM_012423.3 F = 5’-CATAGGAAGCTGGGAGCAAG-3’ Structural component of 60S
ribosomal subunit
R = 5’-GCCCTCCAATCAGTCTTCTG-3’







NM_001135702.1 F = 5’-ACTTTTGGTACATTGTGGCTTCAA-3’ Signal transduction
R = 5’-CCGCCAGGACAAACCAGTAT-3’
Information for the panel of selected reference genes with full name, NCBI reference sequence, forward and reverse primer sequences, and short description of
cellular function.
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closest abundance to the target gene remaining for
further analyses.
Step 2: Initial standard deviation-values from Normfinder
Normfinder selects the most suitable RG based on the
standard deviations (SDs) for intragroup donor variation
and intergroup treatment variation. This analysis was
performed taking the group classification of treatment
into account, in order to verify that the candidate RGsFigure 1 Performance of primer amplification. qPCR endpoint products
indicated above the amplicon.were stably expressed and not regulated by treatment.
The RG candidates with a large bias, an intergroup SD
reaching or exceeding 0.2 were excluded (Table 2), leav-
ing TBP, PPIA, YWHAZ, and GUSB for ASCs and TBP,
PPIA, YWHAZ, GUSB, and GAPDH for BMSCs for the
final analysis.
Step 3: Final output from geNorm and Normfinder
Due to the selection in step 2, the software should not
regard the effect of treatment in the next step of thewere separated by agarose gel electrophoresis. Target genes are
Figure 2 Expression level dot plots of RG candidates. Distribution of median Cq values for ASCs (A) and BMSCs (B) from eight donors in
control medium (blue) and VEGF-treatment medium (red). ASCs; adipose-derived stromal cells, BMSCs; bone marrow-derived stromal cells, RG;
reference gene, VEGF; vascular endothelial growth factor. N = 8 except for vWF where N = 3.
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encompass both intragroup donor variation and inter-
group treatment variation. According to Normfinder
ranking order, TBP was found to be the most stable RG
candidate through the VEGF treatment for both ASCs
and BMSCs (Figure 3A and 3B). The optimal number of
RGs was two for ASCs and four for BMSCs based on
the accumulated SDs, which were reduced slightly by
0.009 and 0.003 respectively when compared to the use
of a single RG (Figure 3C and 3D). In order to determine
which RGs to use in combination we utilize intergroup
treatment variation data calculated by Normfinder using
only the remaining genes from Step 3 (Figure 3E). TheTable 2 Step two of elimination, showing ASC and BMSC
reference gene intergroup variations







Difference in mean expression of each gene between treated and untreated
groups is shown as standard deviations (SD) in unit cycles. Genes were excluded
at a cutoff value above 0.2. Those with a SD below the threshold value (*) were
included considered for further processing. 18S rRNA: 18S ribosomal RNA, ACTB:
beta-actin, EF1-a: Elongation factor 1-alpha, GAPDH: gluco phosphate
dehydrogenase, GUSB: Beta-glucuronidase, PPIA: Peptidylprolyl isomerase A,
RPL13a: Ribosomal protein L13-alpha, TBP: TATA box binding protein, YWHAZ:
Tyrosine 3/tryptophan 5-monooxygenase activation protein. Genes not indicated
with a star (*) were deactivated in GenEx.sum of the different possible combinations were calcu-
lated and compared. The chosen combinations of TBP
and YWHAZ for ASCs and TBP, GAPDH, PPIA and
GUSB for BMSCs yielded a RG variation sum closest to
zero.
GeNorm uses pair-wise comparison and sequential
elimination to select the pair of RGs with highest correl-
ation, indicated by the average expression stability (M).
TBP and GUSB were found to be the best correlated RGs
for ASCs and PPIA and GAPDH for BMSCs (Figure 4A
and 4B) with a cut-off level at 0.5.
RG verification
We compared the effect of normalization to various RG
choices on the expression of a gene of interest (GOI),
vWF, to validate our procedure of stepwise elimination
of RG candidates and to attain a final selection of the
most suitable RGs for future VEGF stimulation experi-
ments. vWF was chosen as positive control since it has
been shown to be upregulated in other experiments by
the same treatment, namely serum-deprivation com-
bined with VEGF stimulation [19,22]. vWF was normal-
ized to RGs from each selection step of our procedure.
For both ASCs and BMSCs, EF1-α was chosen from step 1
while RPL13 was chosen from step 2. From step 3, the sin-
gle best RG found and the optimal number of RGs found
by Normfinder and the two best correlated RGs given by
geNorm were evaluated. Geometric mean of RG combina-
tions were used, as suggested by Vandesompele et al. [14].
For ASCs, vWF was normalized to TBP, the geometric
mean of TBP and YWHAZ (Normfinder), or the geometric
Figure 3 Determination of most stable gene and optimal number of RGs. In the third step of RG selection, the Normfinder algorithm was
used on the genes remaining following the first and second eliminations. Gene ranking according to stability through VEGF treatment of ASCs
(A) and BMSCs (B). Accumulated SDs indicate the best number of RGs for ASCs (C) and BMSCs (D). The intergroup treatment variation as
calculated by Normfinder during Step 3 of the RG selection process (E). The shaded histograms present the single most stable reference gene.
ASCs; adipose-derived stromal cells, BMSC; bone marrow-derived stromal cells, SD; standard deviation. N = 8.
Figure 4 Determination of the best correlated genes. Average expression stability measure (M) calculated by pairwise comparison of RGs
with sequential elimination of least stable RG by geNorm for ASCs (A) and BMSCs (B). The shaded histograms indicate the two most correlated
genes. ASCs; adipose-derived stromal cells, BMSC; bone marrow-derived stromal cells, SD; standard deviation. N = 8.
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the normalization was also performed to TBP alone, to
the geometric mean of TBP, PPIA, GAPDH, and GUSB
(Normfinder), to the geometric mean of PPIA and GAPDH
(geNorm) (Figure 6A). Additionally, vWF was normalized
to the geometric mean of TBP and YWHAZ on the basis
of Figure 6B.
Poor results with normalization to eliminated RGs
For both ASCs and BMSCs, EF1-α was chosen from step
1 while RPL13 was chosen from step 2 and the single
best RG found by Normfinder, TBP, was chosen from
step 3. When comparing the fold difference in vWF ex-
pression for ASCs, no significant increase was observed
for VEGF-treated ASCs compared to controls, regardless
of the RGs used for normalization. The trend in a slight
upregulation of vWF was not investigated in depth, since
this was not the aim of the study. For assessing our elim-
ination procedure, comparison of the use of single RGs
gave different results for the previously eliminated RGs
compared to TBP. The variance in RPL13 results was
markedly larger than the variance in TBP results, while
EF1-α results showed a tendency of down-regulation of
vWF, in contrast to results from all other normalizations.
For BMSC, normalizing to any of the RG combinations
or TBP alone included in step 3 of selection, proved
vWF to be significantly increased by the VEGF treat-
ment. The results are not significant when normalizingFigure 5 Difference in vWF expression normalized to different RGs. N
from geNorm and Normfinder results. Two previously eliminated RGs, EF1-α
reference gene, vWF: von Willebrand Factor. N = 3 and error bars representto EF1α or RPL13, and their variance was greater than
that for TBP.
Evaluating combinations of RGs
Comparing the results from step 3 normalizations for
ASCs, TBP alone produced results almost identical to ei-
ther of the two combinations. Variance was lowest in
TBP and highest in the geNorm combination, yet still
almost identical (Figure 5).
For BMSCs, the fold expression increase obtained
using TBP normalization was slightly below that for
the Normfinder combination of RGs, while the geNorm
combination resulted in a higher fold expression level
(Figure 6A). Since the geNorm combination is the two
best correlated RGs and the Normfinder combination
was the best calculated number of RGs, we trust the ex-
pression level found using the Normfinder combination
to be the most precise.
We further investigated whether a combination of
two RGs could replace the four RG combination sug-
gested by Normfinder for practical purposes. We found
the geometric mean of TBP and YWHAZ to be the
combination with the closest related and nearly identi-
cal vWF fold change level, also with the lowest SEM
across samples (Figure 6B). This combination was com-
pared to the others in Figure 6A. When comparing the
results of vWF expression between the different RG
combinations, only TBP is significantly different fromormalization of vWF to various RGs for ASCs. The RGs were chosen
and RPL13 are included. ASCs; adipose-derived stromal cells, RG;
SEM.
Figure 6 Comparison of BMSC vWF expression results from two-RG-combinations. Normalization of vWF to various RGs for BMSCs (A). The
RGs were chosen by the same method as those in Figure 5. *denotes significant (p < 0.05) vWF change, and † denotes significant correlation with
results using the Normfinder combination of four-RGs. Test of two-RG combinations relative to results from the Normfinder combination of four
genes (B). 2-ΔΔCq data were calculated for each RG combination using the geometric mean of the selected RGs, and compared to the mean of
the results using Normfinder in the RG verification step. §denotes the combination producing results most closely related to those obtained using
the Normfinder four-RG combination, and the combination producing the lowest standard deviation. BMSCs; bone marrow-derived stromal cells,
vWF; von Willebran Factor, RG; Reference Gene, C; Combination. N = 3 and error bars represent SEM.
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using the combination of TBP and YWHAZ, found from
C4 in Figure 6B, were significantly correlated with the
Normfinder combination.
Discussion
We compared different RGs for qPCR to detect the most
optimal RGs for human ASCs and BMSCs, as these cell
types are currently used in clinical trials, where they are
stimulated with VEGF before injection into the myocar-
dium of patients with chronic ischemic heart disease.
When investigating the effect of the growth factor on
the cells on transcriptional level, it is necessary to per-
form RG optimization for the production of properly
normalized, reliable, and reproducible results.The best single RG for both cell types in our experi-
mental setup was TBP, which has been found to be
stable through several other interventions using different
stem cell lines or cancer cells [15,23,24]. TBP and
YWHAZ were found to be the best two-RG combination
for qPCR analyses of VEGF stimulation with serum
deprivation in both ASCs and BMSCs.
Only four RGs were included in the final analysis for
ASCs. It is noteworthy that the reduced panel from
which an RG or combination of RGs was to be selected,
were the exact same RGs that Fink et al. have shown to
have stable expression in ASCs treated with hypoxia
[15]. The other candidate RGs were excluded on the
basis of having intergroup variation above the 0.2 cycle
cutoff or because their expression level was significantly
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excluded RPL13 which was found by several groups to
be the most stable RG in mesenchymal stem cells
through different treatments [25,26].
Though Normfinder found the optimal number of
RGs to be two (Figure 3C), and geNorm found GUSB to
be the RG best correlated with TBP (Figure 4A), the dif-
ference between using TBP alone or in combination with
GUSB was minimal. The inclusion of GUSB only leads
to a reduction of 0.009 in accumulated SD (Figure 3C),
and the variation in fold change of vWF between the
two normalizations was insignificant (Figure 5). Simi-
larly, the combination of TBP and YWHAZ, calculated
from Normfinder, would give the same results as TBP
alone. The geometric mean of this combination even
had a slightly lower variance compared with that of TBP
and GUSB. We suggest that TBP can be used alone or in
combination with YWHAZ or GUSB for ASCs in this
experimental setup.
For BMSCs, five RGs were included in the final ana-
lysis. The elimination explained earlier lead to the exclu-
sion of EF1-α, which is considered to be a very stable
RG, and the inclusion of GAPDH, which has been shown
to be rather unstable through different treatments
[15,27,28]. GeNorm identified the best combination of
two genes to be PPIA and GAPDH (Figure 4B). However,
the use of these two RGs leads to a higher accumulated
SD (Figure 3D), and their geometric mean produced a
larger fold increase in vWF expression compared to the
other combinations (Figure 6A).
The fact that normalizing to the geometric mean of
the two genes chosen by geNorm produced a larger fold
increase in vWF compared to the other combinations is
an example of geNorm calculating pair-wise correlation
rather than stability when selecting the best suited RGs.
The number of RGs to be used as suggested by Norm-
finder was the combination of four genes. The use of
two RGs would increase the accumulated SD by 0.026
(Figure 3D), but due to practical reasons we further ana-
lyzed combinations of two genes to find the normalization
that would produce the most similar result for vWF
expression (Figure 6B). Since TBP and YWHAZ produced
results closest to the combination of the four RGs calcu-
lated by Normfinder and displayed the lowest SEM, we
obtain a combination of RGs similar to that for ASCs,
which could be useful in experimental setups. Except for
the use of TBP as single RG, none of the vWF expression
results using the various combinations were significantly
different from those using the four-RG Normfinder com-
bination. However, the use of the other combinations
could still produce Type 1 or Type 2 errors due to skewed
expression levels or high degree of variance. The C4 com-
bination from Figure 6B, TBP and YWHAZ, was the
only combination significantly correlated to the four-RGNormfinder combination. This result is of course depen-
dent on our choice of the four-RG Normfinder combin-
ation as the most stable. In contrast to BMSCs, the
different RG combinations for ASCs produced more
similar vWF expression results. This could be due to the
seemingly larger impact of the VEGF treatment on
BMSCs, which could likewise have larger influence on
the RG expression, compared to standard culture. We
have recently investigated the effect of VEGF treatment
with serum-deprivation on ASCs, and found that the
treatment did not produce endothelial differentiation to
the same extent as shown earlier on BMSCs stimulated
similarly [19,22].
The importance of using a final GOI-specific test as
supplement to results from the software before choosing
RGs is especially underscored by the BMSC results.
Simply following the results from geNorm would have
resulted in an overestimation of the VEGF effect, which
could severely bias an entire study. The software is very
useful in the elimination process towards the GOI-
specific test, which is evident by our results with RGs
eliminated in the earlier steps. The RG candidate EF1-α
was eliminated early on in the selection process with an
expression level far from that of vWF. For ASCs, using
EF1-α as an RG would be misleading while in BMSCs
there is a large variance. Normalizing to RPL13 also re-
sults in a large variance for both cell types as expected,
since it was eliminated early on for high intergroup vari-
ation. The fact that EF1-α and RPL13 would be unsuit-
able to use as RGs supports our RG selection procedure.
Conclusions
For reliable and reproducible qPCR analyses, selection of
the correct RGs for a given experimental setup is of
prime importance. We have presented a step-by-step
procedure for selecting RGs, with emphasis on a follow-
up test with a gene of interest as the final step in the
selection process. Genes were eliminated based on high
intergroup variations, after which Normfinder and geNorm
were applied for further selection, with a final comparison
of vWF expression levels for optimal RG selection. We
found that the combination of TBP and YWHAZ as RGs is




ASCs were isolated from lipoaspirate obtained from
eight healthy donors of which one was male and seven
were female (age between 28–57 years; mean age 43.4).
BMSCs were obtained from bone marrow aspirate from
eight healthy donors, two males and six females (age
20–46 years; mean age 27.8). The use of ASCs and
BMSCs from healthy volunteers was approved by the
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All donors agreed to and signed the informed consent.
After isolation and cultivation, ASCs and BMSCs were
both stimulated with VEGF and compared with untreated
control.
Bone marrow preparation and BMSC isolation
50 ml bone marrow aspirate was obtained from the iliac
crest by needle aspiration under local anesthesia. The
sample was diluted 1:2 with phosphate-buffered saline
pH 7.4 (PBS, −Ca2+ -Mg2+, Gibco, Invitrogen, Denmark,
cat.no. 10010–015). Mononuclear cells (MNCs) were
harvested by gradient centrifugation on Lymphoprep
(1077 g/cm3, Medinor, Denmark, cat.no. 1114547),
washed with PBS and counted using NucleoCounter®
NC-100™ (Chemometec, Denmark) according to man-
ufacturer’s instructions. Primary cell cultures of MNCs
were established by seeding 2 × 107 cells/T75-flask (Nunc,
Thermo Scientific, Denmark, cat.no. 156494) in complete
medium containing Dulbecco’s Modified Eagle Medium,
low glucose (1 g/l) (DMEM) supplemented with 25 mM
HEPES and L-Glutamin, (PAA Laboratories, Austria, cat.
no. E15-808), 10% Fetal Bovine Serum Farma grade (FBS,
PAA Laboratories, cat.no. A11-512) and 1% Penicillin/
Streptomycin (Gibco, cat.no. 15140–122). The cells were
incubated in standard conditions at 37°C in humid air with
5% CO2. The medium was changed 5 days after initial
seeding, and subsequently every 3–4 days.
Lipoaspirate preparation and ASC isolation
Approximately 100 ml lipoaspirate was obtained from
liposuctions of subcutaneous abdominal fat performed
under local anesthesia. The lipoaspirate was washed twice
with PBS to remove residual blood. The adipose tissue
was digested by incubation with collagenase (Collagenase
NB4 (0.6 PZ U/ml, Serva GmbH, Germany) dissolved
in HBSS (+CaCl2 +MgCl2, GIBCO, cat.no. 14065–049)
diluted to a concentration of 2 mM Ca2+) at 37°C for
45 min. under constant rotation. The collagenase was neu-
tralized with complete medium and the suspension was
filtered through a 100 μl mesh (Cell Strainer, BD Falcon,
cat.no. 352360); centrifuged at 1200 g for 10 min. at room
temperature, re-suspended and counted. MNCs were
seeded at a density of 4.5x106 cells/T75-flask in complete
medium and incubated at standard conditions. After two
days in culture, cells were washed with PBS to remove
non‐adhering leukocytes, and complete medium added
anew with subsequent change of media every three-four
days.
Cell culture
When the culture reached a confluence level of approxi-
mately 90%, cells were washed with PBS, detached with
3 ml TrypLE® (TrypLE® Select, Gibco, cat.no. 12563–029)for 10 min. at 37°C and neutralized with 7 ml complete
medium. The suspension was centrifuged at 300 g for
5 min. at room temperature, counted, and seeded at
3.5x105 cells/T75-flask for the experimental setup. The
cells exhibited stem cell characteristics, by adhering to
plastic, expressing stem cell markers and being able to
differentiate [22,29-31].
Stimulation with VEGF
BMSCs and ASCs were cultured in complete medium
until their confluence was estimated to be 80%. They
were then either kept in complete medium (control), or
changed to serum‐deprived medium (DMEM+ 2%FBS +
1%P/S) added 50 ng/ml recombinant human VEGF‐A165
(rhVEGFA165, R&D Systems, USA, cat.no. 293-VE-CF).
All media was renewed every two-three days and cells
were cultured for one week after which they were har-
vested for further processing.
Nucleic acid extraction
Total RNA was extracted using Qiagen RNeasy® Mini
Kit (Qiagen Hamburg GmbH, Hamburg, Germany,
cat.no. 74106) according to the manufactures protocol.
1 ml syringe (Omnific‐F 1 ml, B.Braun Melsunger AG,
Germany, cat.no. 300013) was used to homogenize the
lysed cells before applying the Qiagen protocol. RNA pur-
ity was measured using NanoDrop® 1000 Spectrophotom-
eter (Thermo Scientific, MA, USA), and the eluate was
stored at −80°C. RNA purity and integrity were confirmed
using RNA Nano Chips (Agilent, Santa Clara, CA, cat.no.
5067–1521) and the Agilent 2100 Bioanalyzer by following
instructions of the Agilent RNA 6000 Nano Kit.
Reverse transcription
The cDNA synthesis reaction was prepared using Affinity-
Script (Stratagene, Denmark, cat.no. 600559) in an eight‐
tube strip (0.1 mL, MicroAmp™, Appied Biosystems®,
Invitrogen, cat.no. 4358293) on ice. The total reaction
volume was 20 μl with 0.5 μg RNA, 10 μl cDNA synthesis
master mix, 3 μl Oligo (dT) primer, 1 μl AffinityScript
RT RNase block enzyme mixture, and RNAse-DNAse
free water to 20 μl total volume. Tubes were closed with
caps (Applied Biosystems, cat.no. N801-0535) and the
reactions were performed with an initial stage of 25°C for
5 min., 42°C for 45 min. and 95°C for 5 min. (Veriti 96
well fast thermal cycler, Applied Biosystems model no.
9901). Following synthesis, the cDNA was stored in
aliquots at −20°C.
Quantiative real-time PCR
qPCR was performed in triplicate per donor for each
group within the same qPCR-run. A calibration curve
was run simultaneously on the RG candidate tested on
the donors. Only data obtained from runs fulfilling the
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the primer verification was included for analysis. The Cq
threshold was set to the value of 0.1 for all qPCR runs.
Brilliant II SYBR®green QPCR Low ROX master mix
(Agilent, cat.no. 600806) was used with a total reaction
volume of 25 μl in 96-well optical reaction plates (Agilent,
cat.no. 401333) with 5 μl of diluted cDNA. The plate was
sealed with optical plastic caps (Agilent, cat.no. 401425).
qPCR was performed using Mx3000 (Stratagene) and the
results were collected using Mx3000 version 4.0 software
for Windows (Stratagene). The reaction was initiated by
heating to 95°C for 10 min., followed by 40 cycles elong-
ation at 60°C for 1 min. and denaturation at 95°C for
30 sec.
To verify the chosen RGs, a normalization experiment
was set up. vWF was used as target gene, and normal-
ized to different combinations of RG candidates. The
level and the standard deviations of the fold changes
between VEGF treated cells and controls were compared
for normalization to different RG combinations. The
fold changes in vWF expression between VEGF treat-
ment and controls were calculated with the 2-ΔΔCq-
method.Gel electrophoresis
A 3% 3–1 NuSieve agarose gel (Lonza, Switzerland, cat.
no. 50090) was made according to the laboratory proto-
col with 1x TAE buffer diluted from 50x TAE buffer
(Qiagen, cat.no. 129237). For visualization of qPCR
products, 10% non-toxic GelStar Nucleic Acid Gel Stain
(Lonza, cat.no. 50535) was added to the melted agarose
before pouring the solution into a plastic well with
combs. After gel solidification the combs were removed
and the solid gel transferred to an electrophoresis tank
(BioRad, CA, USA) and covered with 1 x TAE buffer. For
every 8 μl PCR product, 2 μl Gelpilot 5x loading dye
(Qiagen, cat.no. 1037650) was added and the 10 μl sample
is loaded by directly injecting into the wells. A negative
control was included to show no contamination of the
product. Gelpilot 1 kb ladder (Qiagen, cat.no. SM0318)
were used. The gel was run between 70 and 100 volt in
45 min.– 60 min. and visualized under ultraviolet light.Data analysis
Step 1. Cq values were plotted in Microsoft Excel and
assessed visually for outliers in the lower end.
For further analysis, we used the GenEx software
(MultiD Analyses AB, Sweden), and more specifically its
algorithms Normfinder and geNorm. In short, Normfin-
der selects the most suitable RG based on the standard
deviations (SDs) for intragroup and intergroup variation,
while geNorm compares the RGs pair-wise and performs
sequential elimination resulting in the best correlatedRGs. Average Cq-values of the technical triplicates were
used for analysis.
Step 2. For each cell type, the mean Cq-values of all
RG candidates from all donors were entered in GenEx
for the treatment and control groups.
Step 3. The function Normfinder was performed
taking group classification of treatment into account, in
order to verify that the candidate RGs were stably
expressed and not regulated by treatment. The RG
candidates with SDs reaching or exceeding 0.2 were
removed from the panel by inactivation in the Data
Manager of GenEx before proceeding to the next step.
Normfinder was run again, without taking groups into
account to give the best estimate of the genes’ stabilities
and an assessment of the optimal number of RGs. Lastly,
geNorm was run to determine the best correlated RGs.
The ΔΔCq-method was used when assessing the effect
of VEGF treatment on the expression of vWF normal-
ized to various RGs, with subsequent use of paired t-test
and Pearson’s Correlation in IBM SPSS. Results were
considered significant at p-values below 0.05.
Additional file
Additional file 1: Table S1. RNA Quality. Table S2. Primer Quality.
Figure S1. Dissociation Curves.
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